AKZA Stock Analysis: Akzo Nobel | AS
Specialty Chemicals | AS, Netherlands | Market Cap: 10.887m EUR | 12M Return: 15.8% | NL0013267909 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.4M
EPS Trend: 58.5%
Qual. Beats: 0
Rev. Trend: -86.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Akzo Nobel N.V. is a Dutch producer of paints and coatings, headquartered in Amsterdam and operating globally through two segments: Decorative Paints and Performance Coatings. Its Decorative Paints arm offers paints, enamels, varnishes, and surface preparation products, along with mixing machines, color concepts, and applicator training, while Performance Coatings supplies engineered coatings with functional properties such as corrosion and fouling control, fire protection, and scratch resistance for ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities.
The company markets its products under a broad brand portfolio that includes Dulux, Sikkens, International, Interpon, Hammerite, Pintuco, Flexa, and Taubmans, serving end markets such as construction, infrastructure, energy, packaging, shipbuilding, and general industrial applications. Akzo Nobel traces its origins to 1646 and adopted its current name in 1994 following the merger that formed Akzo Nobel.
As a specialty chemicals business within the broader Materials sector, Akzo Nobel combines a consumer-facing decorative paints franchise with a higher-specification industrial coatings portfolio, where brand equity, technical service, and product performance certification typically drive competitive positioning. Earnings are closely linked to global construction and renovation activity, automotive and aerospace production cycles, and industrial maintenance spending.
- Decorative paints pricing and volumes drive margin recovery
- Raw material costs including titanium dioxide pressure gross margins
- Performance coatings demand tied to automotive and industrial cycles
| Net Income: 636.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.49 > 1.0 |
| NWC/Revenue: 38.52% < 20% (prev 11.10%; Δ 27.42% < -1%) |
| CFO/TA 0.06 > 3% & CFO 911.0m > Net Income 636.0m |
| Net Debt (3.40b) to EBITDA (1.65b): 2.06 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (171.4m) vs 12m ago -0.48% < -2% |
| Gross Margin: 40.70% > 18% (prev 39.85%; Δ 0.85% > 0.5%) |
| Asset Turnover: 65.30% > 50% (prev 74.28%; Δ -8.98% > 0%) |
| Interest Coverage Ratio: 7.0 > 6 (EBIT TTM 1.27b / Interest Expense TTM 182.0m) |
| A: 0.24 (Total Current Assets 8.12b - Total Current Liabilities 4.31b) / Total Assets 16.1b |
| B: 0.33 (Retained Earnings 5.36b / Total Assets 16.1b) |
| C: 0.08 (EBIT TTM 1.27b / Avg Total Assets 15.2b) |
| D: 0.44 (Book Value of Equity 4.85b / Total Liabilities 11.1b) |
| Altman-Z'' = 3.66 = AA |
| DSRI: 1.09 (Receivables 2.90b/2.82b, Revenue 9.89b/10.5b) |
| GMI: 0.98 (GM 39.85% / 40.70%) |
| AQI: 0.89 (AQ_t 0.35 / AQ_t-1 0.39) |
| SGI: 0.94 (Revenue 9.89b / 10.5b) |
| TATA: -0.02 (NI 636.0m - CFO 911.0m) / TA 16.1b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of August 15, 2026, the stock is trading at EUR 62.28 with a total of 355,319 shares traded. Over the past week, the price has changed by -2.01%, over one month by +8.35%, over three months by +25.95% and over the past year by +15.76%.
Current recommended Stop Loss: 59.20 (which is 4.9% or 2.2 ATR below the current price).
Akzo Nobel has no consensus analysts rating.
P/E Trailing = 17.0753
P/E Forward = 17.2712
P/S = 1.1004
P/B = 2.2434
P/EG = 2.784
Revenue TTM = 9.89b EUR
EBIT TTM = 1.27b EUR
EBITDA TTM = 1.65b EUR
Long Term Debt = 3.48b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.09b EUR (from shortTermDebt, last quarter)
Debt = 6.87b EUR (from shortLongTermDebtTotal, last quarter) + Leases 274.0m
Net Debt = 3.40b EUR (calculated: Debt 6.87b - CCE 3.46b)
Enterprise Value = 14.3b EUR (10.9b + Debt 6.87b - CCE 3.46b)
Interest Coverage Ratio = 7.0 (Ebit TTM 1.27b / Interest Expense TTM 182.0m)
EV/FCF = 22.86x (Enterprise Value 14.3b / FCF TTM 625.0m)
FCF Yield = 4.37% (FCF TTM 625.0m / Enterprise Value 14.3b)
FCF Margin = 6.32% (FCF TTM 625.0m / Revenue TTM 9.89b)
Net Margin = 6.43% (Net Income TTM 636.0m / Revenue TTM 9.89b)
Gross Margin = 40.70% ((Revenue TTM 9.89b - Cost of Revenue TTM 5.87b) / Revenue TTM)
Gross Margin QoQ = 41.95% (prev 40.99%)
Tobins Q-Ratio = 0.89 (Enterprise Value 14.3b / Total Assets 16.1b)
Interest Expense / Debt = 2.65% (Interest Expense 182.0m / Debt 6.87b)
Taxrate = 34.32% (348.0m / 1.01b)
NOPAT = 836.8m (EBIT 1.27b * (1 - 34.32%))
Current Ratio = 1.88 (Total Current Assets 8.12b / Total Current Liabilities 4.31b)
Debt / Equity = 1.41 (Debt 6.87b / totalStockholderEquity, last quarter 4.85b)
Debt / EBITDA = 2.06 (Net Debt 3.40b / EBITDA 1.65b)
Debt / FCF = 5.44 (Net Debt 3.40b / FCF TTM 625.0m)
Total Stockholder Equity = 4.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.20% (Net Income 636.0m / Total Assets 16.1b)
RoE = 13.88% (Net Income TTM 636.0m / Total Stockholder Equity 4.58b)
RoCE = 15.81% (EBIT 1.27b / Capital Employed (Equity 4.58b + L.T.Debt 3.48b))
RoIC = 6.74% (NOPAT 836.8m / Invested Capital 12.4b)
WACC = 5.18% (E(10.9b)/V(17.8b) * Re(7.35%) + D(6.87b)/V(17.8b) * Rd(2.65%) * (1-Tc(0.34)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 22.33 | Cagr: 0.21%
[DCF] Terminal Value 77.97% ; FCFF base≈567.0m ; Y1≈650.0m ; Y5≈956.6m
[DCF] Fair Price = 64.14 (EV 14.4b - Net Debt 3.40b = Equity 11.0b / Shares 171.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 58.48 | EPS CAGR: 6.19% | SUE: -0.68 | # QB: 0
Revenue Correlation: -86.26 | Revenue CAGR: -2.83% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.11 | Chg30d=+13.49% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=3.92 | Chg30d=+1.68% | Revisions=+31% | GrowthEPS=+8.0% | GrowthRev=-1.2%
EPS next Year (2027-12-31): EPS=4.29 | Chg30d=+0.67% | Revisions=+27% | GrowthEPS=+9.6% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +34% (up=18, down=8)